newsfilter
← Latest News
GlobeNewswire·

AVITA Medical to Host Investor Webinar Briefing

  • AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) will host an investor webinar on Wednesday, November 11, 2026, at 2:00 p.m. Pacific Time featuring President & CEO Cary Vance and CFO David O'Toole.
  • The presentation will review financial results from the third quarter of 2026 earnings webcast followed by a Q&A session.
  • Registration for the Zoom webinar is available via the provided link, with a replay accessible on the investor relations website post-event.
  • AVITA Medical focuses on therapeutic acute wound care using RECELL technology, which is FDA-approved for thermal burn and trauma wounds to create Spray-On Skin™.
  • In the U.S., the company holds exclusive rights to market Cohealyx® collagen-based dermal matrix and to manufacture, market, sell, and distribute PermeaDerm® biosynthetic wound matrix.
  • Internationally, RECELL is CE-marked in Europe, TGA-certified in Australia, listed with Medsafe in New Zealand, PMDA-approved in Japan, and approved for various skin healing applications.
Company
AVITA Medical
Keywords
Australian Stock Exchange:AVH.AX, AVITA Medical